Slip Disc Market information, by types (thoracic herniated discs, lumbar herniated disc, and others), by diagnosis (physical examination, nerve conduction test, and others), by treatment (medications, therapy, and others) - global forecast till 2030

1 Report Prologue

2 Introduction

2.1 Introduction

2.2 Research Objective

2.3 Assumptions & Limitations

2.3.1 Assumptions

2.3.2 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.1.1 Growing Cases of Spinal Injuries

4.1.2 Growing awareness of spinal non-fusion procedures

4.1.3 Growing Adoption of Sedentary Lifestyle

4.1.4 Growing Prevalence of Obese Population Affecting Spinal Injuries

4.2 Restrains

4.2.1 Treatment Cost

4.2.2 Ethical and Social Concerns

4.2.3 Complications Involved

4.3 Opportunities

4.3.1 Development of New Alternative Treatment Method

4.3.2 Botulinum-A Toxin Injections for Treatment Spinal Cord Injuries

5 Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Introduction

5.1.2 Bargaining Power of Suppliers

5.1.3 Bargaining Power of Buyers

5.1.4 Threat of New Entrants

5.1.5 Threat of Substitutes

5.1.6 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 Introduction

5.2.2 Primary Activities

5.2.3 Secondary Activities

6 Global Slip disc market by Types

6.1 Introduction

6.2 Thoracic Herniated Discs

6.3 Lumbar Herniated Disc

6.4 Cervical Herniated Discs

7 Slip Disc Market, By Diagnosis

7.1 Introduction

7.2 Physical Examination

7.3 Nerve Conduction Test

7.4 Imaging Tests

8 Slip Disc Market, By Treatment

8.1 Introduction

8.2 Medications

8.3 Therapy

8.4 Surgery

9 Global Slip Disc Market, By Regions

9.1 Introduction

9.2 Americas

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.2.1 Americas

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.2.1.1 US

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.2.1.2 Canada

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.2.2 Latin America

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3 Europe

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.1 Germany

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.2 France

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.3 UK

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.4 Italy

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.5 Spain

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.3.6 Rest of Europe

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4 Asia Pacific

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.1 Japan

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.2 China

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.3 India

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.4 Republic of Korea

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.5 Australia

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.4.6 Rest of Asia Pacific

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.5 Middle East & Africa

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.5.1 Middle East

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

9.5.2 Africa

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

10 Competitive landscape

Slip Disc Market, By Diagnosis

Slip Disc Market, By Treatment

10.1 Introduction

10 Competitive landscape

10.1 Introduction

11 Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 TEVA Pharmaceutical LTD.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financials

11.2.4 Key Developments

11.3 GlaxoSmithKline plc.

11.3.1 Company Overview

11.3.2 Product overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.)

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Key Developments

11.4.4 Financials

11.4.5 SWOT Analysis

11.5 NuVasive, Inc.

11.5.1 Overview

11.5.2 Product Overview

11.5.3 Financials

11.5.4 Key Developments

11.6 Captiva Spine, Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Development

11.7 Globus Medical, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments